NanoString Technologies Inc.

218 articles with NanoString Technologies Inc.

• NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference - May 27, 2021

  5/27/2021

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast a presentation from the Jefferies Virtual Healthcare Conference.

• NanoString to Webcast Presentation from the UBS Global Healthcare Conference

  5/20/2021

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast a presentation from the UBS Global Healthcare Conference.

• NanoString's GeoMx Mouse Whole Transcriptome Atlas Expands Leadership in Spatial Genomics by Enabling Genome-Wide RNA Profiling

  5/17/2021

  Accelerating Discovery by Providing High Throughput Spatial Analysis of any RNA Target in the Primary Model Organism for Discovery

• NanoString Technologies Releases Operating Results for First Quarter of 2021

  5/10/2021

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2021.

• NanoString’s Digital Spatial Profiling Platform Used to Create Foundational Dataset Revealing Insights into COVID-19

  5/4/2021

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that a peer-reviewed publication using the GeoMx® Digital Spatial Profiler is to be published in the journal Nature.

• 

  Companies Showcase Data in Multiple Cancers Ahead of 2021 Virtual AACR Meeting

  4/9/2021

  Data on multiple oncology therapeutic programs are being unveiled ahead of the start of the annual American Association for Cancer Research meeting, which will be held virtually this year due to the ongoing COVID-19 pandemic.

• NanoString Highlights Spatial Biology Research from the 2021 American Association of Cancer Research (AACR) Conference

  4/8/2021

  GeoMx Breast Cancer Consortium (GBCC) Provides Early Spatial Insights into Tumors, the Tumor Microenvironment, and the Host Immune Response

• NanoString to Release First Quarter 2021 Operating Results and Host Conference Call on Monday, May 10, 2021

  4/6/2021

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will release first quarter 2021 operating results after the close of the market on Monday, May 10, 2021.

• NanoString's GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications

  3/31/2021

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that two peer-reviewed publications using the GeoMx® Digital Spatial Profiler have been published in Nature and Nature Communications.

• NanoString, Illumina Accelerator and Doloromics Announce GeoMx Digital Spatial Profiling Collaboration to Develop Novel Pain Therapeutics

  3/22/2021

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the company has awarded a Technology Access Program grant with Illumina Accelerator startup, Doloromics, focused on gaining a deeper understanding of chronic pain diseases by spatially characterizing the dorsal root ganglion (DRG)

• 

  BioSpace Movers & Shakers, March 12

  3/12/2021

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

• NanoString Appoints Dr. Dana Rollison and Janet George to Board of Directors

  3/9/2021

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the appointment of two new board members, Dr. Dana Rollison and Janet George, effective March 8, 2021.

• NanoString Technologies Releases Fourth Quarter and Full Year 2020 Operating Results and Provides 2021 Financial Outlook

  3/1/2021

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and year ended December 31, 2020.

• NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference

  3/1/2021

  NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of a Technology Access Program (TAP) for the Spatial Molecular Imager.

• NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference

  2/24/2021

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast a presentation from the 41st Annual Cowen Healthcare Conference.

• NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021

  2/22/2021

  Whole Transcriptome Atlas Extends Leadership in Spatial Genomics by Enabling Highly Sensitive Genome-Wide RNA Profiling on GeoMx Digital Spatial Profiler

• NanoString to Webcast Presentation from the 10th Annual SVB Leerink Global Healthcare Conference

  2/17/2021

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast a presentation from the 10th Annual SVB Leerink Global Healthcare Conference.

• NanoString to Release Fourth Quarter and Fiscal Year 2020 Operating Results and Host Conference Call on Monday, March 1, 2021

  2/11/2021

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will release fourth quarter and fiscal year 2020 operating results after the close of the market on Monday, March 1, 2021.

• Nature Medicine Publishes First Study Utilizing NanoString’s GeoMx Digital Spatial Profiler Whole Transcriptome Atlas

  2/9/2021

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the publication of a study in the journal Nature Medicine that used NanoString’s GeoMx® Digital Spatial Profiler and the new Whole Transcriptome Atlas to profile sarcoma tissue.

• NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020

  1/10/2021

  Q4 Product and Service Revenue of $35.7 Million, Including GeoMx Revenue of $12.2 million, Exceeding High End of Guidance Ranges